The evaluation of microbiology and Fournier's gangrene severity index in 27 patients

Basit Öğe Kaydı
dc.contributor.authorUlug, Mehmet
dc.contributor.authorGedik, Ercan
dc.contributor.authorGirgin, Sadullah
dc.contributor.authorCelen, Mustafa K.
dc.contributor.authorAyaz, Celal
dc.date.accessioned2024-04-24T16:14:53Z
dc.date.available2024-04-24T16:14:53Z
dc.date.issued2009
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjectives: The objectives of this study were to identify the causative microorganisms and factors associated with survival in patients with Fournier's gangrene and to determine the accuracy of the Fournier's gangrene severity index. Materials and methods: We retrospectively evaluated 27 patients with Fournier's gangrene who were treated and followed up at our hospital between January 2005 and December 2006. Biochemical, hematologic, and bacteriologic study results at admission and at the final evaluation, etiologic and predisposing factors at admission, physical examination findings, the timing and extent of surgical debridement, and antibiotic therapy used were all recorded. Results: The admission laboratory parameters that were significantly correlated with outcome included urea, creatinine, sodium, and potassium; at the final evaluation, in addition to these parameters, hematocrit, albumin, and bicarbonate levels were also significantly associated with outcome. The mean Fournier's gangrene severity index score (FGSIS) at admission for survivors was 5.04 + 2.49 compared with 13.6 + 4.61 for non-survivors. There was a strong correlation between the FGSIS and mortality (p < 0.0001). Escherichia coli and Pseudomonas aeruginosa were the most commonly isolated microorganisms. Conclusions: Patient metabolic status and predisposing factors are important in the prognosis of Fournier's gangrene. Hence, we believe that the FGSIS should be used clinically to evaluate therapeutic options and assess results. (C) 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.ijid.2009.01.021
dc.identifier.endpageE430en_US
dc.identifier.issn1201-9712
dc.identifier.issn1878-3511
dc.identifier.issue6en_US
dc.identifier.pmid19411184
dc.identifier.scopus2-s2.0-70350568830
dc.identifier.scopusqualityQ1
dc.identifier.startpageE424en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijid.2009.01.021
dc.identifier.urihttps://hdl.handle.net/11468/15488
dc.identifier.volume13en_US
dc.identifier.wosWOS:000271373400033
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.ispartofInternational Journal of Infectious Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFournier's Gangreneen_US
dc.subjectMicrobiologyen_US
dc.subjectPrognosisen_US
dc.titleThe evaluation of microbiology and Fournier's gangrene severity index in 27 patientsen_US
dc.titleThe evaluation of microbiology and Fournier's gangrene severity index in 27 patients
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu